Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04791761Phase 2Terminated
Phase 2, randomised, open-label trial of ibuprofen and acetaminophen in postoperative pain (3 arms). Primary endpoint: Average Pain Burden at 14 days. Started Apr 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04791761.